All Stories

  1. Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry
  2. Management and Outcomes of Childhood Renal Artery Stenosis and Middle Aortic Syndrome
  3. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients after Cessation of Antiviral Prophylaxis
  4. A Perspective on Inherited Kidney Disease
  5. The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease
  6. Association of Arterial Stiffness and Central Pressure With Cognitive Function in Incident Hemodialysis Patients: The PACE Study
  7. How to stent the ureter after kidney transplantation in children?-A comparison of two methods of urinary drainage
  8. Validation of serum creatinine-based formulae in pediatric renal transplant recipients
  9. Cardiovascular Structure and Function in Children With Middle Aortic Syndrome and Renal Artery StenosisNovelty and Significance
  10. Nephrotic syndrome in infants and children: pathophysiology and management
  11. Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients
  12. Incidence and risk factors of early surgical complications in young renal transplant recipients: A persistent challenge
  13. Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers
  14. Longitudinal assessment of myocardial function in childhood chronic kidney disease, during dialysis, and following kidney transplantation
  15. Parental Health Literacy and Outcomes of Childhood Nephrotic Syndrome
  16. The Authors Reply
  17. Very-Low Frequency Heart Rate Variability is Depressed During Hemodialysis Session
  18. Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis
  19. The Rivas Cohort Study: design and baseline characteristics of a Nicaraguan cohort
  20. Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome
  21. Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network
  22. The evolving science of apolipoprotein-L1 and kidney disease
  23. Ethnic Differences in Childhood Nephrotic Syndrome
  24. Parental attitudes to genetic testing differ by ethnicity and immigration in childhood nephrotic syndrome: a cross-sectional study
  25. Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study
  26. Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis
  27. Frailty and Cognitive Function in Incident Hemodialysis Patients
  28. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression
  29. Calcium and Sudden Cardiac Death in End-Stage Renal Disease
  30. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study
  31. A new grading system for the management of antenatal hydronephrosis in children
  32. Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa
  33. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators
  34. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study
  35. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study
  36. Chronic kidney disease prevalence in Rivas, Nicaragua: Use of a field device for creatinine measurement
  37. INCREASED QT VARIABILITY INDEX IS ASSOCIATED WITH MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS
  38. Rituximab for patients with nephrotic syndrome
  39. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis
  40. Health-Related and Psychosocial Concerns about Transplantation among Patients Initiating Dialysis
  41. Troponin I and NT-proBNP and the Association of Systolic Blood Pressure With Outcomes in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study
  42. Pharmacological interventions for hypertension in children
  43. Cochrane in context: Pharmacological interventions for hypertension in children
  44. Patient- and Provider-Reported Information about Transplantation and Subsequent Waitlisting
  45. The New Histopathologic Classification of ANCA-Associated GN and Its Association with Renal Outcomes in Childhood
  46. Prophylactic Defibrillators in Patients With Severe Chronic Kidney Disease
  47. Age and Sex Disparities in Discussions About Kidney Transplantation in Adults Undergoing Dialysis
  48. Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study
  49. Pharmacological interventions for hypertension in children
  50. Biomarkers of Vascular Calcification and Mortality in Patients with ESRD
  51. APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
  52. Host APOL1 genotype is independently associated with proteinuria in HIV infection
  53. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators
  54. APOL1 Variants Associate with Increased Risk of CKD among African Americans
  55. Antiretroviral-Treated HIV-Infected Women Have Similar Long-Term Kidney Function Trajectories as HIV-Uninfected Women
  56. CLINICAL PREDICTORS OF CORONARY ARTERY CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS: THE PACE (PREDICTORS OF ARRHYTHMIC AND CARDIOVASCULAR RISK IN END-STAGE RENAL DISEASE) STUDY
  57. The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome
  58. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans
  59. Effects of Sodium Intake and Diet on Racial Differences in Urinary Potassium Excretion: Results From the Dietary Approaches to Stop Hypertension (DASH)-Sodium Trial
  60. Donor and Recipient APOL1/MYH9 Risk Alleles Are not Associated with Risk for Kidney Allograft Loss
  61. Net endogenous acid production is associated with a faster decline in GFR in African Americans
  62. Serum  -Trace Protein and Risk of Mortality in Incident Hemodialysis Patients
  63. Genetic Association and Gene-Gene Interaction Analyses in African American Dialysis Patients With Nondiabetic Nephropathy
  64. Expect the Unexpected: Sudden Cardiac Death in Dialysis Patients
  65. Endpoints for Hemodialysis Access Procedures: Correlation between Fistulography and Intraaccess Blood Flow Measurements
  66. Chronic Kidney Disease and Estimates of Kidney Function in HIV Infection: A Cross-Sectional Study in the Multicenter AIDS Cohort Study
  67. CKD Treatment: Time to Alter the Focus to Albuminuria?
  68. The MYH9/APOL1 region and chronic kidney disease in European-Americans
  69. Soluble P-Selectin Levels Are Associated with Cardiovascular Mortality and Sudden Cardiac Death in Male Dialysis Patients
  70. The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in HIV-Infected Women
  71. Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study
  72. Genetic epidemiology of chronic kidney disease
  73. Genetic Basis of Nondiabetic End-Stage Renal Disease
  74. Predictors and consequences of higher estimated glomerular filtration rate at dialysis initiation
  75. Metabolic syndrome: signs and symptoms running together
  76. Association of APOEpolymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study
  77. Pharmacological interventions for essential hypertension in children
  78. Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study
  79. Clinical Testing Patterns and Cost Implications of Variation in the Evaluation of CKD Among US Physicians
  80. Association of Single-Nucleotide Polymorphisms in JAK3, STAT4, and STAT6 With New Cardiovascular Events in Incident Dialysis Patients
  81. The association of sudden cardiac death with inflammation and other traditional risk factors
  82. Ability of Blood Pressure to Predict Left Ventricular Hypertrophy in Children with Primary Hypertension
  83. Incidence of Atherosclerotic Cardiovascular Disease Among HIV Patients Receiving Dialysis
  84. Clinical Outcomes and Dialysis Adequacy in Adolescent Hemodialysis Patients
  85. Renal Function and Heart Disease
  86. Cardiovascular disease in patients with kidney disorders in childhood and adolescence
  87. Getting Serious About Pediatric Chronic Kidney Disease
  88. Preferences, Knowledge, Communication and Patient-Physician Discussion of Living Kidney Transplantation in African American Families
  89. Cardiovascular complications in pediatric end-stage renal disease
  90. Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy
  91. The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation
  92. Alcohol: role in the development of hypertension and end-stage renal disease
  93. Neoral induction in pediatric renal transplantation
  94. Dialysis Support in the Pediatric Intensive Care Unit
  95. Catch-up Growth in Cystinotic Children with Specified Nutrition. 2184